39.31
-0.15 (-0.38%)
-0.15 (-0.38%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Editas Medicine Inc | EDIT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.15 | -0.38% | 39.31 | 19:58:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 40.69 | 38.25 | 40.69 | 39.51 | 39.46 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 39.01 | 39.51 | 0.50 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18,272 | 1,095,744 | $ 39.73 | $ 43,529,887 | 3,902,301 | 21.41 - 99.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:24 | 1 | $ 39.03 | USD |
Editas Medicine Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.47B | 62.87M | 62.81M | $ 20.53M | $ -13.84M | -2.68 | -38.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Editas Medicine News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EDIT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 44.51 | 45.431 | 38.25 | 41.29 | 1,071,373 | -5.20 | -11.68% |
| 1 Month | 46.35 | 49.17 | 37.14 | 43.18 | 1,542,610 | -7.04 | -15.19% |
| 3 Months | 74.00 | 76.8999 | 36.10 | 53.34 | 2,425,226 | -34.69 | -46.88% |
| 6 Months | 33.60 | 99.95 | 27.12 | 57.67 | 2,245,708 | 5.71 | 16.99% |
| 1 Year | 22.06 | 99.95 | 21.41 | 49.31 | 1,590,057 | 17.25 | 78.2% |
| 3 Years | 34.89 | 99.95 | 14.01 | 37.98 | 1,078,828 | 4.42 | 12.67% |
| 5 Years | 37.48 | 99.95 | 12.43 | 33.90 | 964,742 | 1.83 | 4.88% |
Editas Medicine Description
| Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company only operating segment being developing and commercializing genome editing technology. |
